Evidence map›Paper›PMID 33821935›Full record

Trial reportAesthetic surgery journal2021

Prospective, Randomized, Comparative Study of the Cutaneous Effects of a Topical Body Treatment Compared to a Bland Moisturizer.

Jean Carruthers, Gyasi Bourne, Michaela Bell, Alan Widgerow

Erratum issuedOpen access · hybridAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Aesthetic surgery journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Review
  3. Prejuvenation: The Global New Anti-Aging Trend.Aesthetic surgery journal. Open forum · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Jean CarruthersCarruthers Instruments Inc., Vancouver, British Columbia, Canada.
Gyasi BourneCarruthers Instruments Inc., Vancouver, British Columbia, Canada.
Michaela BellAlastin Skincare, Inc., Carlsbad, CA, USA.
Alan WidgerowAlastin Skincare, Inc., Carlsbad, CA, USA.

Funding

Alastin Skin Care Inc.Carruthers Instruments Inc
6 · The paper itself

Abstract

backgroundOver time human skin thins and loses elasticity; topical treatments attempt to reverse this process.

objectivesThe aim of this study was to assess the efficacy of TransFORM Body Treatment (TFB) in skin rejuvenation compared to a bland moisturizer on the extensor and volar forearms.

methodsBlinded participants were given 2 products to apply on the designated forearms with follow-up at 4, 8, and 12 weeks. Measurements included skin thickness, photography, dermatopathology, cutaneous elasticity determined by 2 different methods, and patient-reported outcomes. All were compared to baseline.

resultsChanges between bland moisturizer and TFB were recorded for the following parameters. (1) Roughness: extensor -0.09 mm for bland moisturizer and -0.26 mm for TFB (P = 0.174); volar 0.01 mm for bland moisturizer and -0.23 mm for TFB (P = 0.004). (2) Recoil velocity: volar -56°/sec for bland moisturizer and -24°/sec for TFB (P = 0.61); extensor -95°/sec for bland moisturizer and -63°/sec for TFB (P = 0.57). Retraction speed: volar -3.25 ms for bland moisturizer and -20.08 ms for TFB (P = 0.33); extensor -2.17 ms for bland moisturizer and -10.83 ms for TFB (P = 0.66). Histologically, TFB resulted in an increase in mucopolysaccharide content, new collagen, and number of elastin fibers in the papillary dermis. Changes in the Rao-Goldman score were also observed: volar -0.17 for bland moisturizer and -0.33 for TFB (P = 0.25); extensor -0.08 for bland moisturizer and -0.17 for TFB (P = 0.36).

conclusionsHistology showed production of new collagen and elastin. Quantification of changes in skin thickness, skin retraction speed, and skin recoil velocity showed trends that agree with the visual data. LEVEL OF EVIDENCE: 4:

Indexed as

SkinAdministration, CutaneousHumansProspective StudiesTreatment Outcome

Identifiers

PMID33821935
PMCPMC8361352
OpenAlexW3147410779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.